Abstract
Meta-analysis statistically assesses the results (e.g., effect sizes) across independent studies that are conducted in accordance with similar protocols and objectives. Current genomic meta-analysis studies do not perform extensive re-analysis on raw data because full data access would not be commonplace, although the best practice of open research for sharing well-formed data have been actively advocated. This chapter describes a simple and easy-to-follow method for conducting meta-analysis of multiple studies without using raw data. Examples for meta-analysis of microRNAs (miRNAs) are provided to illustrate the method. MiRNAs are potential biomarkers for early diagnosis and epigenetic monitoring of diseases. A number of miRNAs have been identified to be differentially expressed, i.e., overexpressed or underexpressed, under diseased states but only a small fraction would be highly effective biomarkers or therapeutic targets of diseases. The meta-analysis method as described in this chapter aims to identify the miRNAs that are consistently found dysregulated across independent studies as biomarkers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Koricheva J, Gurevitch J (2013) Place of meta-analysis among other methods of research synthesis. In: Koricheva J, Gurevitch J, Mengersen K (eds) Handbook of meta-analysis in ecology and evolution. Princeton University Press
Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009) Introduction to meta-analysis. John Wiley & Sons, Ltd., Chichester. https://doi.org/10.1002/9780470743386
Evangelou E, Ioannidis JPA (2013) Meta-analysis methods for genome-wide association studies and beyond. Nat Rev Genet 14:379–389. https://doi.org/10.1038/nrg3472
Levinson DF (2005) Meta-analysis in psychiatric genetics. Curr Psychiatry Rep 7:143–151. https://doi.org/10.1007/s11920-005-0012-9
Borenstein M (2009) Effect sizes for continuous data. In: Cooper H, Hedges LV, Valentine JC (eds) The handbook of research synthesis and meta-analysis. Russell Sage Foundation
Tseng GC, Ghosh D, Feingold E (2012) Comprehensive literature review and statistical considerations for microarray meta-analysis. Nucleic Acids Res 40:3785–3799. https://doi.org/10.1093/nar/gkr1265
Zhu H, Leung SW (2015) Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies. Diabetologia 58:900–911. https://doi.org/10.1007/s00125-015-3510-2
Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (reprinted from annals of internal medicine). Phys Ther 89:873–880. https://doi.org/10.1371/journal.pmed.1000097
Minimum information about a microarray experiment – MIAME. http://www.mged.org/Workgroups/MIAME/miame_2.0.html
Kahn SE (2001) Clinical review 135: the importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86:4047–4058
Karolina DS, Armugam A, Sepramaniam S, Jeyaseelan K (2012) MiRNAs and diabetes mellitus. Expert Rev Endocrinol Metab 7:281–300. https://doi.org/10.1586/eem.12.21
Winer N, Sowers JR (2004) Epidemiology of diabetes. J Clin Pharmacol 44:397–405. https://doi.org/10.1177/0091270004263017
International Diabetes Federation (IDF) (2015) IDF Diabetes Atlas, 7th edn. idf.org. doi:https://doi.org/10.1289/image.ehp.v119.i03
Shantikumar S, Caporali A, Emanueli C (2012) Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res 93:583–593. https://doi.org/10.1093/cvr/cvr300
Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A (2004) Identification of mammalian microRNA host genes and transcription units. Genome Res 14(10):1902. https://doi.org/10.1101/gr.2722704
Lee Y, Kim M, Han J et al (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23:4051–4060. https://doi.org/10.1038/sj.emboj.7600385
He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5:522–531. https://doi.org/10.1038/nrg1379
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297. https://doi.org/10.1016/S0092-8674(04)00045-5
Arroyo JD, Chevillet JR, Kroh EM et al (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 108:5003–5008. https://doi.org/10.1073/pnas.1019055108
Vickers KC, Palmisano BT, Shoucri BM et al (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13:423–433. https://doi.org/10.1038/ncb2210
Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O (2009) Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol 11:1143–1149. https://doi.org/10.1038/ncb1929
Suárez Y, Sessa WC (2009) MicroRNAs as novel regulators of angiogenesis. Circ Res 104:442–454. https://doi.org/10.1161/CIRCRESAHA.108.191270
Carrington JC, Ambros V (2003) Role of microRNAs in plant and animal development. Science 301:336–338. https://doi.org/10.1126/science.1085242
Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79:351–379. https://doi.org/10.1146/annurev-biochem-060308-103103
Bagge A, Clausen TR, Larsen S et al (2012) MicroRNA-29a is up-regulated in beta-cells by glucose and decreases glucose-stimulated insulin secretion. Biochem Biophys Res Commun 426:266–272. https://doi.org/10.1016/j.bbrc.2012.08.082
Karolina DS, Tavintharan S, Armugam A et al (2012) Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab 97:E2271–E2276. https://doi.org/10.1210/jc.2012-1996
Locke JM, Harries LW (2012) MicroRNA expression profiling of human islets from individuals with and without type 2 diabetes: promises and pitfalls. Biochem Soc Trans 40:800–803. https://doi.org/10.1042/BST20120049
Liu J, Liu W, Ying H et al (2012) Analysis of microRNA expression profile induced by AICAR in mouse hepatocytes. Gene 512:364–372. https://doi.org/10.1016/j.gene.2012.09.118
Begley CG, Ellis LM (2012) Raise standards for preclinical cancer research. Nature 483:531–533. https://doi.org/10.1038/483531a
Prinz F, Schlange T, Asadullah K (2011) Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov 10:712. https://doi.org/10.1038/nrd3439-c1
Mobley A, Linder SK, Braeuer R et al (2013) A survey on data reproducibility in cancer research provides insights into our limited ability to translate findings from the laboratory to the clinic. PLoS One 8:e63221. https://doi.org/10.1371/journal.pone.0063221
Guay C, Roggli E, Nesca V et al (2011) Diabetes mellitus, a microRNA-related disease? Transl Res 157:253–264. https://doi.org/10.1016/j.trsl.2011.01.009
Guay C, Jacovetti C, Nesca V (2012) Emerging roles of non-coding RNAs in pancreatic β-cell function and dysfunction. Diabetes Obes Metab 14:12–21
Hamar P (2012) Role of regulatory microRNAs in type 2 diabetes mellitus related inflammation. Nucleic Acids Ther 22:289–294
McClelland AD, Kantharidis P (2014) MicroRNA in the development of diabetic complications. Clin Sci (Lond) 126:95–110. https://doi.org/10.1042/CS20130079
Natarajan R, Putta S, Kato M (2012) MicroRNAs and diabetic complications. J Cardiovasc Transl Res 5:413–422
Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36:1–48
Centre for Reviews and Dissemination (2009) Systematic reviews: CRDs guidance for undertaking reviews in health care. Cent Rev Dissemination, Univ York, 2008. https://doi.org/10.1017/CBO9781107415324.004
Park N, Zhou H, Elashoff D (2009) Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 15:5473–5477
Hanke M, Hoefig K, Merz H et al (2010) A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol 28:655–661. https://doi.org/10.1016/j.urolonc.2009.01.027
Weber JA, Baxter DH, Zhang S et al (2010) The microRNA spectrum in 12 body fluids. Clin Chem 56:1733–1741
Yamada Y, Enokida H, Kojima S et al (2011) MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Sci 102:522–529. https://doi.org/10.1111/j.1349-7006.2010.01816.x
Bustin S, Benes V, Garson J et al (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611–622. https://doi.org/10.1373/clinchem.2008.112797
R Core Team (2015) R: A language and environment for statistical computing. R Found Stat Comput, Vienna, Austria 0:{ISBN} 3-900051-07-0. doi:ISBN 3-900051-07-0
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
1 Electronic Supplementary Material
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Zhu, H., Leung, Sw. (2018). Identification of Potential MicroRNA Biomarkers by Meta-analysis. In: Gore, M., Jagtap, U. (eds) Computational Drug Discovery and Design. Methods in Molecular Biology, vol 1762. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7756-7_24
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7756-7_24
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7755-0
Online ISBN: 978-1-4939-7756-7
eBook Packages: Springer Protocols